As the “one-size-fits-all” nutritional model becomes less relevant, consumer interest in personalized nutrition and ‘taking back control’ is growing, but the past 15 years are littered with harsh lessons. So, why are today’s companies better positioned...
By analysing the long-lasting commitments and acquisition activity of major companies Dr Matthew Jones at CPL Business Consultants uses the Red Queen theory to develop an understanding of their corporate mind-set and appetite for acquisitions and partnerships...
Just got off the phone to Ola Snove, the new(ish) CEO of Aker part-owned Norwegian omega-3 specialist Epax. Wanted to know his view on high-end omega-3 prospects that have attracted BASF and DSM to the sector. His word: “Stellar”.
BASF is moving en masse into omega-3 - especially if its bid for Norwegian player Pronova is approved - but it is technology gained from its May acquisition of a high-dose omega-3 start-up on a remote Scottish island, that is exciting the German giant.
Interview: Samy Jandali, VP Nutrition & Health, North America, BASF
One year on from the $3.1 billion acquisition of Cognis, Samy Jandali, VP of nutrition and health North America for BASF, told Stephen Daniells why he is impressed with the progress of the integration and why we can expect more M&A in the nutrition...
Improved logistics and optimised process control technology resulting from a multi million euro investment in its Danish microencapsulation facility will allow greater flexibility in terms of carotenoid and vitamin powder delivery to manufacturers, claims...
Germany chemicals group BASF is implementing a new measure to
combat price pressure on its vitamin businesses in the long-term,
by combining its human and animal nutrition resources under the
banner of a new nutrition unit within...
BASF's fine chemicals division reported a huge rise in operating
profits in second quarter 2006 - no thanks to vitamins. Rather,
credit is given to a swift trade in aroma chemicals and gains from
contract manufacturing and personal...
BASF's fine chemicals division is bolstered by higher sales volume
of aroma chemicals and vitamins A and E for animal nutrition, but
the pressure over vitamin C and lysine has not abated, dragging
down the division's profitability.
BASF and Daiichi, two of the companies involved in the 1990s
vitamin cartel, have had their fines significantly reduced by a
European court, which ruled that the Commission made errors when
calculating the fines.
The German chemicals giant BASF has announced a successful second
quarter, though the company's nutrition and agricultural products
division turned in a poor performance with minimal sales growth and
reduced earnings from the...
The world's number two vitamin maker BASF officially opened its new
vitamin B2 plant in Korea today, increasing its production capacity
for the food and feed grade vitamin and reinforcing its position in
the consolidating vitamins...
The world's number two vitamin maker BASF boosted second quarter
earnings in its agricultural and nutrition segment, despite flat
sales from across the group's businesses and a pessimistic outlook
for the full year.
German chemicals group BASF said this week that while on schedule
with its expansion of vitamin E production, first announced in
2001, it was anticipating supply bottlenecks at its Ludwigshafen
plant between now and April next year.
German chemicals group BASF said it performed well last year and is
confident of further growth in 2002 despite difficult trading
conditions. All of the company's divisions performed well, despite
high raw material prices and...